A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-04-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/4/e025897.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823857276367142912 |
---|---|
author | Susan M Donath Monsurul Hoq Vicky Karlaftis Susan Mathews Janet Burgess John Carlin Paul Monagle Vera Ignjatovic |
author_facet | Susan M Donath Monsurul Hoq Vicky Karlaftis Susan Mathews Janet Burgess John Carlin Paul Monagle Vera Ignjatovic |
author_sort | Susan M Donath |
collection | DOAJ |
description | Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes.Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers.Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories. |
format | Article |
id | doaj-art-521549691dee433c9e1d1adfc0ac3677 |
institution | Kabale University |
issn | 2044-6055 |
language | English |
publishDate | 2019-04-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj-art-521549691dee433c9e1d1adfc0ac36772025-02-11T22:50:08ZengBMJ Publishing GroupBMJ Open2044-60552019-04-019410.1136/bmjopen-2018-025897A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocolSusan M Donath0Monsurul Hoq1Vicky Karlaftis2Susan Mathews3Janet Burgess4John Carlin5Paul Monagle6Vera Ignjatovic7Clinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, Melbourne, Victoria, AustraliaClinical Epidemiology and Biostatistics, Murdoch Children`s Research Institute, Parkville, Victoria, Australia3 Department of Haematology Research, Murdoch Children’s Research Institute, Parkville, Victoria, Australia4 Department of Biochemistry, Laboratory Services, The Royal Children’s Hospital, Parkville, Victoria, Australia5 Department of Pathology Collection, Laboratory Services, The Royal Children’s Hospital, Parkville, Victoria, Australia1 Department of Paediatrics, The University of Melbourne, Parkville, Australia2 Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia6 Institute for Clinical and Translational Research, Johns Hopkins All Children`s Hospital, St Petersburg, Florida, USAIntroduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes.Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers.Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories.https://bmjopen.bmj.com/content/9/4/e025897.full |
spellingShingle | Susan M Donath Monsurul Hoq Vicky Karlaftis Susan Mathews Janet Burgess John Carlin Paul Monagle Vera Ignjatovic A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol BMJ Open |
title | A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol |
title_full | A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol |
title_fullStr | A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol |
title_full_unstemmed | A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol |
title_short | A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol |
title_sort | prospective cross sectional study to establish age specific reference intervals for neonates and children in the setting of clinical biochemistry immunology and haematology the happi kids study protocol |
url | https://bmjopen.bmj.com/content/9/4/e025897.full |
work_keys_str_mv | AT susanmdonath aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT monsurulhoq aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT vickykarlaftis aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT susanmathews aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT janetburgess aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT johncarlin aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT paulmonagle aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT veraignjatovic aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT susanmdonath prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT monsurulhoq prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT vickykarlaftis prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT susanmathews prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT janetburgess prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT johncarlin prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT paulmonagle prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol AT veraignjatovic prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol |